Super Generics Market - Global Outlook and Forecast 2022-2028

January 2022 | 61 pages | ID: S9C2D768AB10EN
Market Monitor Global

Abstracts

The huge cost of drug development and the time overruns to develop new therapeutics have hindered innovation in the drug research and development space by promoting companies to find alternatives to maintain patent protection for a given brand. Super generics or modified therapeutic entities are an excellent form of a given generic drug molecule, which has better patient compliance and therapeutic effect than existing generic drugs.

This report contains market size and forecasts of Super Generics in Global, including the following market information:

Global Super Generics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Super Generics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Super Generics include Sun Pharmaceutical Industries, Meda Pharmaceuticals, Taiwan Liposome Company, Dr. Reddy’s Laboratories, Allergan, Teva Pharmaceutical and Celgene Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Super Generics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Super Generics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Super Generics Market Segment Percentages, by Type, 2021 (%)

• Oral
• Injectable
• Others

Global Super Generics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Super Generics Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Super Generics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Super Generics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Super Generics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Super Generics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sun Pharmaceutical Industries
• Meda Pharmaceuticals
• Taiwan Liposome Company
• Dr. Reddy’s Laboratories
• Allergan
• Teva Pharmaceutical
• Celgene Corporation

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Super Generics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Super Generics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SUPER GENERICS OVERALL MARKET SIZE

2.1 Global Super Generics Market Size: 2021 VS 2028
2.2 Global Super Generics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Super Generics Players in Global Market
3.2 Top Global Super Generics Companies Ranked by Revenue
3.3 Global Super Generics Revenue by Companies
3.4 Top 3 and Top 5 Super Generics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Super Generics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Super Generics Players in Global Market
  3.6.1 List of Global Tier 1 Super Generics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Super Generics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Super Generics Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Injectable
  4.1.4 Others
4.2 By Type - Global Super Generics Revenue & Forecasts
  4.2.1 By Type - Global Super Generics Revenue, 2017-2022
  4.2.2 By Type - Global Super Generics Revenue, 2023-2028
  4.2.3 By Type - Global Super Generics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Super Generics Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Super Generics Revenue & Forecasts
  5.2.1 By Application - Global Super Generics Revenue, 2017-2022
  5.2.2 By Application - Global Super Generics Revenue, 2023-2028
  5.2.3 By Application - Global Super Generics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Super Generics Market Size, 2021 & 2028
6.2 By Region - Global Super Generics Revenue & Forecasts
  6.2.1 By Region - Global Super Generics Revenue, 2017-2022
  6.2.2 By Region - Global Super Generics Revenue, 2023-2028
  6.2.3 By Region - Global Super Generics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Super Generics Revenue, 2017-2028
  6.3.2 US Super Generics Market Size, 2017-2028
  6.3.3 Canada Super Generics Market Size, 2017-2028
  6.3.4 Mexico Super Generics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Super Generics Revenue, 2017-2028
  6.4.2 Germany Super Generics Market Size, 2017-2028
  6.4.3 France Super Generics Market Size, 2017-2028
  6.4.4 U.K. Super Generics Market Size, 2017-2028
  6.4.5 Italy Super Generics Market Size, 2017-2028
  6.4.6 Russia Super Generics Market Size, 2017-2028
  6.4.7 Nordic Countries Super Generics Market Size, 2017-2028
  6.4.8 Benelux Super Generics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Super Generics Revenue, 2017-2028
  6.5.2 China Super Generics Market Size, 2017-2028
  6.5.3 Japan Super Generics Market Size, 2017-2028
  6.5.4 South Korea Super Generics Market Size, 2017-2028
  6.5.5 Southeast Asia Super Generics Market Size, 2017-2028
  6.5.6 India Super Generics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Super Generics Revenue, 2017-2028
  6.6.2 Brazil Super Generics Market Size, 2017-2028
  6.6.3 Argentina Super Generics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Super Generics Revenue, 2017-2028
  6.7.2 Turkey Super Generics Market Size, 2017-2028
  6.7.3 Israel Super Generics Market Size, 2017-2028
  6.7.4 Saudi Arabia Super Generics Market Size, 2017-2028
  6.7.5 UAE Super Generics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sun Pharmaceutical Industries
  7.1.1 Sun Pharmaceutical Industries Corporate Summary
  7.1.2 Sun Pharmaceutical Industries Business Overview
  7.1.3 Sun Pharmaceutical Industries Super Generics Major Product Offerings
  7.1.4 Sun Pharmaceutical Industries Super Generics Revenue in Global Market (2017-2022)
  7.1.5 Sun Pharmaceutical Industries Key News
7.2 Meda Pharmaceuticals
  7.2.1 Meda Pharmaceuticals Corporate Summary
  7.2.2 Meda Pharmaceuticals Business Overview
  7.2.3 Meda Pharmaceuticals Super Generics Major Product Offerings
  7.2.4 Meda Pharmaceuticals Super Generics Revenue in Global Market (2017-2022)
  7.2.5 Meda Pharmaceuticals Key News
7.3 Taiwan Liposome Company
  7.3.1 Taiwan Liposome Company Corporate Summary
  7.3.2 Taiwan Liposome Company Business Overview
  7.3.3 Taiwan Liposome Company Super Generics Major Product Offerings
  7.3.4 Taiwan Liposome Company Super Generics Revenue in Global Market (2017-2022)
  7.3.5 Taiwan Liposome Company Key News
7.4 Dr. Reddy’s Laboratories
  7.4.1 Dr. Reddy’s Laboratories Corporate Summary
  7.4.2 Dr. Reddy’s Laboratories Business Overview
  7.4.3 Dr. Reddy’s Laboratories Super Generics Major Product Offerings
  7.4.4 Dr. Reddy’s Laboratories Super Generics Revenue in Global Market (2017-2022)
  7.4.5 Dr. Reddy’s Laboratories Key News
7.5 Allergan
  7.5.1 Allergan Corporate Summary
  7.5.2 Allergan Business Overview
  7.5.3 Allergan Super Generics Major Product Offerings
  7.5.4 Allergan Super Generics Revenue in Global Market (2017-2022)
  7.5.5 Allergan Key News
7.6 Teva Pharmaceutical
  7.6.1 Teva Pharmaceutical Corporate Summary
  7.6.2 Teva Pharmaceutical Business Overview
  7.6.3 Teva Pharmaceutical Super Generics Major Product Offerings
  7.6.4 Teva Pharmaceutical Super Generics Revenue in Global Market (2017-2022)
  7.6.5 Teva Pharmaceutical Key News
7.7 Celgene Corporation
  7.7.1 Celgene Corporation Corporate Summary
  7.7.2 Celgene Corporation Business Overview
  7.7.3 Celgene Corporation Super Generics Major Product Offerings
  7.7.4 Celgene Corporation Super Generics Revenue in Global Market (2017-2022)
  7.7.5 Celgene Corporation Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Super Generics Market Opportunities & Trends in Global Market
Table 2. Super Generics Market Drivers in Global Market
Table 3. Super Generics Market Restraints in Global Market
Table 4. Key Players of Super Generics in Global Market
Table 5. Top Super Generics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Super Generics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Super Generics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Super Generics Product Type
Table 9. List of Global Tier 1 Super Generics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Super Generics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Super Generics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Super Generics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Super Generics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Super Generics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Super Generics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Super Generics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Super Generics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Super Generics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Super Generics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Super Generics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Super Generics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Super Generics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Super Generics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Super Generics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Super Generics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Super Generics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Super Generics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Super Generics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Super Generics Revenue, (US$, Mn), 2023-2028
Table 30. Sun Pharmaceutical Industries Corporate Summary
Table 31. Sun Pharmaceutical Industries Super Generics Product Offerings
Table 32. Sun Pharmaceutical Industries Super Generics Revenue (US$, Mn), (2017-2022)
Table 33. Meda Pharmaceuticals Corporate Summary
Table 34. Meda Pharmaceuticals Super Generics Product Offerings
Table 35. Meda Pharmaceuticals Super Generics Revenue (US$, Mn), (2017-2022)
Table 36. Taiwan Liposome Company Corporate Summary
Table 37. Taiwan Liposome Company Super Generics Product Offerings
Table 38. Taiwan Liposome Company Super Generics Revenue (US$, Mn), (2017-2022)
Table 39. Dr. Reddy’s Laboratories Corporate Summary
Table 40. Dr. Reddy’s Laboratories Super Generics Product Offerings
Table 41. Dr. Reddy’s Laboratories Super Generics Revenue (US$, Mn), (2017-2022)
Table 42. Allergan Corporate Summary
Table 43. Allergan Super Generics Product Offerings
Table 44. Allergan Super Generics Revenue (US$, Mn), (2017-2022)
Table 45. Teva Pharmaceutical Corporate Summary
Table 46. Teva Pharmaceutical Super Generics Product Offerings
Table 47. Teva Pharmaceutical Super Generics Revenue (US$, Mn), (2017-2022)
Table 48. Celgene Corporation Corporate Summary
Table 49. Celgene Corporation Super Generics Product Offerings
Table 50. Celgene Corporation Super Generics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Super Generics Segment by Type in 2021
Figure 2. Super Generics Segment by Application in 2021
Figure 3. Global Super Generics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Super Generics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Super Generics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Super Generics Revenue in 2021
Figure 8. By Type - Global Super Generics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Super Generics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Super Generics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Super Generics Revenue Market Share, 2017-2028
Figure 12. US Super Generics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Super Generics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Super Generics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Super Generics Revenue Market Share, 2017-2028
Figure 16. Germany Super Generics Revenue, (US$, Mn), 2017-2028
Figure 17. France Super Generics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Super Generics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Super Generics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Super Generics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Super Generics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Super Generics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Super Generics Revenue Market Share, 2017-2028
Figure 24. China Super Generics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Super Generics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Super Generics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Super Generics Revenue, (US$, Mn), 2017-2028
Figure 28. India Super Generics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Super Generics Revenue Market Share, 2017-2028
Figure 30. Brazil Super Generics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Super Generics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Super Generics Revenue Market Share, 2017-2028
Figure 33. Turkey Super Generics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Super Generics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Super Generics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Super Generics Revenue, (US$, Mn), 2017-2028
Figure 37. Sun Pharmaceutical Industries Super Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Meda Pharmaceuticals Super Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Taiwan Liposome Company Super Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Dr. Reddy’s Laboratories Super Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Allergan Super Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Teva Pharmaceutical Super Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Celgene Corporation Super Generics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)